Effects of empagliflozin on progression of chronic kidney disease: a pre-specified secondary analysis from the EMPA-KIDNEY trial
HAYNES R., HERRINGTON W., STAPLIN N., Judge P., EMBERSON J., PREISS D., Mayne K., SAMMONS E., ZHU D., HILL M., STEVENS W., WALLENDSZUS K., LANDRAY M., BAIGENT C.